Global physically-backed gold ETFs racked up their largest six-month inflow since H1 2020 in this year's January-to-June ...

Capital Group Growth trades at cheaper valuations than index-focused growth ETFs, with a strong quant rating and attractive ...

Emergent BioSolutions (EBS) has secured a $51.9M contract modification award to deliver CNJ-016 to the Administration for Strategic Preparedness and Response (A ...

Vor Biopharma pivots to telitacicept with $175M funding, eyeing multi-billion potential. Risks include dilution, regulatory ...